PIROXICAM DOC CREMA 50G 1%

PIROXICAM DOC 1% CREMA

active ingredients

100 g cream contain 1 g pyroxicam. Excipients with known effects: propylene glycol, cetostearilic alcohol. For the full list of excipients, see paragraph 6.1.

Excellent

Polyethyleneglycol 1000 monocetyletere, propylene glycol, cetostearilic alcohol, phenylethylene alcohol, anallergical perfume, polyglycolic esters of fatty acids, purified water.

Therapeutic indications

Painful states of rheumatic, flogistic or traumatic nature of the joints, muscles, tendons and ligaments (artritis, periartriti, arthrosis at various localization phases in reacutization, synovitis, tendonitis, tenosinovitis, borsiti, contusioni, distorsioni, lineages, postumi di lussazioni, mialgies, brachialgia, lom).

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in the paragraph 6.1. Piroxicam is contraindicated in case of pregnancy, ascertained or presumed, and nursing.

Population

Spread 2-3 cm of cream on the sore part slowly massaging until completely absorbed, repeating the administration 2-3 or more times a day.

Conservation

This medicine does not require any special condition of conservation.

Warnings

See paragraphs 4.5 and 4.6. Piroxicam has been reported cases of eruption fixed by drugs (FDE). Piroxicam should not be reintroduced in patients with anamnesi of FDE related to piroxicam. There may be a potential crusade reaction with other oxicams. PIROXICAM DOC contains propylene glycol This medicine contains 7 g of glycol propylene per 100 g. It can cause skin irritation. To be considered if used on open wounds or extended areas of damaged skin (such as burns). PIROXICAM DOC contains cetostearilic alcohol This medicine contains cetosterial alcohol that can cause reactions on the localized skin (e.g. contact dermatitis). PIROXICAM DOC contains allergens This medicine contains an aroma in turn containing cumarin allergens, 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, linalol, benzil benzoato, citronellol. Such allergens may cause allergic reactions.

Interactions

Based on bioavailability studies it is extremely unlikely that piroxicam cream will spy on other drugs related to plasma proteins. However, doctors will have to monitor patients treated with PIROXICAM DOC cream and high-binding protein drugs for any dosage adjustments.

Effects

The use of the product, especially if prolonged, can give rise to phenomena of local sensitization or irritation. In this case it is necessary to stop the treatment and establish suitable therapy. Effects with frequency not known: eruption fixed by drugs (see paragraph 4.4). Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

No overdosing of the product has been reported.

Piroxicam is contraindicated in case of pregnancy, ascertained or presumed, and nursing.

Source: Farmadati